BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the treatment of solid tumors, ...
Dr. Laila El-Khattabi (Sorbonne University Hospitals and the Brain Institute, Paris, France) will share results from the CHROMAPS project, a multi-institutional European collaboration utilizing OGM to ...
A scientific poster session showcasing successful CTSC-connected research ... should include a faculty member from Case Western Reserve University (CWRU), Cleveland Clinic, MetroHealth Medical Center, ...
Posters presented at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference show that therapeutic ...
Interested contributors have until 2 May 2025 to submit abstracts for scientific posters ... medical physicists, medical radiation technologists and regulatory authorities. Contributors interested in ...